Teresa Sousa Selected Research

Teresa Sousa Research Topics

Disease

13	Hypertension (High Blood Pressure) 01/2019 - 04/2002
5	Obesity 08/2017 - 01/2016
4	Insulin Resistance 01/2021 - 01/2016
4	Heart Failure 01/2021 - 06/2014
3	Overweight 01/2021 - 01/2016
2	Fibrosis (Cirrhosis) 11/2020 - 01/2016
2	Inflammation (Inflammations) 10/2020 - 01/2016
2	Hypertrophy 01/2016 - 03/2005
2	Hyperplasia 07/2008 - 03/2005
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Autism Spectrum Disorder 05/2019
1	Autistic Disorder (Autism) 05/2019
1	Motor Disorders 01/2017
1	Kidney Diseases (Kidney Disease) 03/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2015
1	Visceral Leishmaniasis (Kala Azar) 01/2014
1	Leukemia 01/2014

Drug/Important Bio-Agent (IBA)

10	Purinergic P1 Receptors (Adenosine Receptor)IBA 11/2020 - 04/2002
8	1,3-dipropyl-8-(4-sulfophenyl)xanthine (PSPX)IBA 07/2008 - 04/2002
4	AntioxidantsIBA 01/2021 - 07/2008
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 03/2005
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Angiotensin IIIBA 01/2019 - 11/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 07/2008
2	Adenosine (Adenocard)FDA LinkGeneric 11/2020 - 03/2014
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016 - 07/2008
2	Purinergic P1 Receptor AntagonistsIBA 02/2006 - 03/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2003 - 04/2002
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	Proline (L-Proline)FDA Link 01/2019
1	AngiotensinogenIBA 08/2017
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2017
1	AldosteroneIBA 03/2016
1	CytokinesIBA 03/2016
1	SaltsIBA 02/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2016
1	NitratesIBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	NitritesIBA 01/2016
1	IsoprostanesIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	EnzymesIBA 01/2016
1	LipidsIBA 01/2016
1	LipoxinsIBA 06/2014
1	EicosanoidsIBA 06/2014
1	Superoxides (Superoxide)IBA 07/2008
1	1,3-dipropyl-8-cyclopentylxanthineIBA 03/2005
1	Caffeine (No Doz)FDA LinkGeneric 03/2005
1	XanthineIBA 02/2004
1	Losartan (Cozaar)FDA LinkGeneric 04/2003
1	Captopril (Capoten)FDA LinkGeneric 04/2003
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2003
1	Atenolol (Tenormin)FDA LinkGeneric 04/2003
1	AngiotensinsIBA 11/2002
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2002
1	ReninIBA 11/2002
1	Potassium Chloride FDA LinkGeneric 11/2002

Therapy/Procedure

3	Neurofeedback 01/2020 - 12/2015
1	Therapeutics 01/2021
1	Secondary Prevention 01/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2014